The increase in price target by UBS suggests a positive outlook on Eastman Chemical's stock value in the short term, potentially leading to an upward movement in its stock price. However, the maintenance of a Neutral rating indicates that the analyst sees the company as fairly valued at its current price, balancing the potential for both growth and risk.